Cardiac Fibrosis and Heart Failure: Cause or Effect?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Advances in Biochemistry in Health and Disease

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/978-3-319-17437-2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Current and Future Strategies for the Diagnosis and Treatment of Cardiac Fibrosis

  2015influential reference
• miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling.

  2014cited by this paper
• Molecular Imaging of the Cardiac Extracellular Matrix

  2014influential reference
• The profibrotic role of endothelin-1: is the door still open for the treatment of fibrotic diseases?

  2014cited by this paper
• Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis

  2014cited by this paper
• What is measured by cardiac fibrosis biomarkers and imaging?

  2014influential reference
• Imatinib Mesylate Attenuates Myocardial Remodeling Through Inhibition of Platelet-Derived Growth Factor and Transforming Growth Factor Activation in a Rat Model of Hypertension

  2014cited by this paper
• The Mineralocorticoid Receptor Promotes Fibrotic Remodeling in Atrial Fibrillation*

  2014cited by this paper
• T1 Mapping Detects Pharmacological Retardation of Diffuse Cardiac Fibrosis in Mouse Pressure-Overload Hypertrophy

  2014influential reference
• Biomarker and imaging responses to spironolactone in subclinical diabetic cardiomyopathy.

  2014influential reference
• Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.

  2013cited by this paper
• Nifedipine inhibits angiotensin II-induced cardiac fibrosis via downregulating Nox4-derived ROS generation and suppressing ERK1/2, JNK signaling pathways.

  2013cited by this paper
• Effects of Direct Renin Inhibition on Myocardial Fibrosis and Cardiac Fibroblast Function

  2013cited by this paper
• Oxidative stress and transforming growth factor-β1-induced cardiac fibrosis.

  2013cited by this paper
• Endothelin receptor blocker bosentan inhibits hypertensive cardiac fibrosis in pressure overload-induced cardiac hypertrophy in rats

  2013cited by this paper
• The effects of carvedilol on cardiac structural remodeling: the role of endogenous nitric oxide in the activity of carvedilol.

  2013cited by this paper
• MicroRNAs, transforming growth factor beta‐1, and tissue fibrosis

  2013cited by this paper
• CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.

  2013cited by this paper
• The Therapeutic Potential of miRNAs in Cardiac Fibrosis: Where Do We Stand?

  2013cited by this paper
• HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.

  2013cited by this paper
• Pirfenidone and the Inflammasome: Getting to the Heart of Cardiac Remodeling

  2013cited by this paper
• Angiotensin II upregulates K(Ca)3.1 channels and stimulates cell proliferation in rat cardiac fibroblasts.

  2013cited by this paper
• Pirfenidone Attenuates Cardiac Fibrosis in a Mouse Model of TAC-Induced Left Ventricular Remodeling by Suppressing NLRP3 Inflammasome Formation

  2013cited by this paper
• Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure

  2013influential reference
• Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.

  2013influential reference
• Renin inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling.

  2013cited by this paper
• Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials

  2013cited by this paper
• Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade

  2013influential reference
• Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts.

  2013influential reference
• Transient receptor potential (TRP) channels and cardiac fibrosis.

  2013cited by this paper
• Myocardial fibrosis and QTc are reduced following treatment with spironolactone or amiloride in stroke survivors: a randomised placebo-controlled cross-over trial.

  2013influential reference
• Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction

  2013cited by this paper
• Therapy for Fibrotic Diseases: Nearing the Starting Line

  2013cited by this paper
• MicroRNAs Involved in the Regulation of Postischemic Cardiac Fibrosis

  2013cited by this paper
• Noninvasive imaging of myocardial extracellular matrix for assessment of fibrosis

  2013influential reference
• Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy.

  2013influential reference
• Fibrosis in heart failure subtypes.

  2013influential reference
• Where do we stand with IPF treatment?

  2013cited by this paper
• Angiotensin Receptor Blockers Are Associated with Reduced Fibrosis and Interleukin-6 Expression in Calcific Aortic Valve Disease

  2013cited by this paper
• Usefulness of high-sensitivity cardiac troponin T and brain natriuretic peptide as biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

  2013influential reference
• Increase in Cellular Cyclic AMP Concentrations Reverses the Profibrogenic Phenotype of Cardiac Myofibroblasts: A Novel Therapeutic Approach for Cardiac Fibrosis

  2013cited by this paper
• Tgfβ-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves.

  2013cited by this paper
• Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice

  2013influential reference
• Carvedilol

  2012cited by this paper
• Combined use of direct renin inhibitor and carvedilol in heart failure with preserved systolic function.

  2012cited by this paper
• Association of galectin‐3 and fibrosis markers with long‐term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE‐HF (Cardiac Resynchronization in Heart Failure) trial

  2012influential reference
• Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.

  2012cited by this paper
• Serum collagen markers and heart failure.

  2012influential reference
• Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats

  2012cited by this paper
• The impact of TGF-β on lung fibrosis: from targeting to biomarkers.

  2012cited by this paper
• Induction of Cardiac Fibrosis by β-Blocker in G Protein-independent and G Protein-coupled Receptor Kinase 5/β-Arrestin2-dependent Signaling Pathways*

  2012cited by this paper
• Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.

  2012cited by this paper
• Adenoviral gene transfer of endothelin-1 in the lung induces pulmonary fibrosis through the activation of focal adhesion kinase.

  2012cited by this paper
• Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation.

  2012cited by this paper
• Non-cardiomyocyte microRNAs in heart failure.

  2012cited by this paper
• Ketamine‐induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol

  2012cited by this paper
• miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice.

  2012cited by this paper
• Syntheses and characterization of lisinopril-coated gold nanoparticles as highly stable targeted CT contrast agents in cardiovascular diseases.

  2012influential reference
• Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve?

  2012cited by this paper
• Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

  2012cited by this paper
• MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles

  2012cited by this paper
• Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.

  2012cited by this paper
• Synergistic roles of scleraxis and Smads in the regulation of collagen 1α2 gene expression.

  2012cited by this paper
• Anti-fibrotic effect of Aliskiren in rats with deoxycorticosterone induced myocardial fibrosis and its potential mechanism.

  2012influential reference
• Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial

  2012influential reference
• Platelet-derived growth factor involvement in myocardial remodeling following infarction.

  2011influential reference
• Effect of anaerobic digestion on the high rate of nitritation, treating piggery wastewater.

  2011cited by this paper
• Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats

  2011cited by this paper
• Transforming growth factor (TGF)-β signaling in cardiac remodeling.

  2011cited by this paper
• Transforming Growth Factor β1 Oppositely Regulates the Hypertrophic and Contractile Response to β-Adrenergic Stimulation in the Heart

  2011cited by this paper
• Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.

  2011cited by this paper
• Scleraxis is Required for Differentiation of the Stapedius and Tensor Tympani Tendons of the Middle Ear

  2011cited by this paper
• Protective effects of statin on cardiac fibrosis and apoptosis in adrenomedullin-knockout mice treated with angiotensin II and high salt loading

  2011cited by this paper
• A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.

  2011influential reference
• Carvedilol-Afforded Protection against Daunorubicin-Induced Cardiomyopathic Rats In Vivo: Effects on Cardiac Fibrosis and Hypertrophy

  2011influential reference
• The single-molecule mechanics of the latent TGF-β1 complex.

  2011cited by this paper
• Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders.

  2011cited by this paper
• TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.

  2011cited by this paper
• Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening.

  2011influential reference
• Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats

  2011cited by this paper
• Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.

  2011cited by this paper
• Aging and Cardiac Fibrosis.

  2011influential reference
• High-Dose Enalapril Treatment Reverses Myocardial Fibrosis in Experimental Uremic Cardiomyopathy

  2011influential reference
• Candesartan Decreases Type III Procollagen-N-Peptide Levels and Inflammatory Marker Levels and Maintains Sinus Rhythm in Patients With Atrial Fibrillation

  2010influential reference
• Cardiovascular Effects in Rats following Exposure to a Receptor Tyrosine Kinase Inhibitor

  2010cited by this paper
• Passive Stiffness of Myocardium From Congenital Heart Disease and Implications for Diastole

  2010influential reference
• Endothelin 1 contributes to the effect of transforming growth factor beta1 on wound repair and skin fibrosis.

  2010cited by this paper
• ADAMTS-1 contributes to the antifibrotic effect of captopril by accelerating the degradation of type I collagen in chronic viral myocarditis.

  2010influential reference
• Endothelin-1 Increases Collagen Accumulation in Renal Mesangial Cells by Stimulating a Chemokine and Cytokine Autocrine Signaling Loop*

  2010cited by this paper
• Nifedipine activates PPARgamma and exerts antioxidative action through Cu/ZnSOD independent of blood-pressure lowering in SHRSP.

  2010cited by this paper
• Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: Expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts

  2010cited by this paper
• Myocardial Calcification and Hypertension following Chronic Renal Failure and Ameliorative Effects of Furosemide and Captopril

  2010influential reference
• Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril

  2010influential reference
• The myofibroblast: paradigm for a mechanically active cell.

  2010cited by this paper
• Of fads, fashion, surrogate endpoints and dual RAS blockade.

  2010cited by this paper
• Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor‐β1 in cultured cardiac fibroblasts

  2010cited by this paper
• Efficacy of olmesartan and nifedipine on recurrent hypoxia-induced left ventricular remodeling in diabetic mice.

  2010cited by this paper
• Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction.

  2010cited by this paper
• Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives

  2010influential reference
• Connective tissue growth factor and cardiac fibrosis

  2009influential reference

• Heart-on-a-chip: a revolutionary organ-on-chip platform for cardiovascular disease modeling

  2025cites this paper
• A Dynamic Gradient Stiffness Material Platform to Manipulate Cardiac Fibroblasts' Spatio‐Temporal Behavior

  2024cites this paper
• Antisenescence Therapy Improves Function in a Human Model of Cardiac Fibrosis-on-a-Chip

  2023cites this paper
• Characterization of Matrix Metalloprotease-9 Gene from Nile tilapia (Oreochromis niloticus) and Its High-Level Expression Induced by the Streptococcus agalactiae Challenge

  2020cites this paper
• Cadherin-11 and cardiac fibrosis: A common target for a common pathology.

  2020cites this paper
• Acellular Extracellular Matrix Bioscaffolds for Cardiac Repair and Regeneration

  2019cites this paper
• [Fibrogenesis Genes and Susceptibility to Coronary Atherosclerosis].

  2018cites this paper
• FGF-2 inhibits contractile properties of valvular interstitial cell myofibroblasts encapsulated in 3D MMP-degradable hydrogels

  2018cites this paper
• Hexarelin treatment preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarction

  2018cites this paper
• MAST CELLS IMPROVE CARDIAC FUNCTION TRANSIENTLY AFTER AN MI AND MODULATE DIFFERENTIATION/PROLIFERATION STAGE OF MESENCHYMAL STEM CELLS THROUGH PDGF

  2017cites this paper
• Mechanobiology of Cardiac Disease and Fibrosis: a Novel Role for Cadherin-11

  2016cites this paper
• Myofibroblast secretome and its auto-/paracrine signaling

  2016cites this paper